Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-02-05
1999-10-05
Witz, Jean C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530399, 530324, 435 681, A61K 3820
Patent
active
059624043
ABSTRACT:
An enzymatically-producible dimeric IL-2 such as mammalian, more particularly, human dimeric IL-2, having oligodendrocyte cytotoxic activity, is useful as active ingredient of pharmaceutical compositions for inducing and facilitating regeneration of injured nerves of the central nervous system in mammals, including humans.
REFERENCES:
Kovarova et al., SBornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Supplementum. 32(4): 397-411 (1989). Abstract., 1989.
Eisenbach-Schwartz Michal
Eitan Shoshana
Witz Jean C.
Yeda Research & Development Co. Ltd.
LandOfFree
Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 fa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 fa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 fa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171380